Matthew Klein Net Worth & Insider Trades

Matthew Klein - CHIEF EXECUTIVE OFFICER, Ptc Therapeutics, Inc

As of April 20, 2023

What is Matthew Klein's Net Worth?

The current estimated net worth of Ptc Therapeutics, Inc's CHIEF EXECUTIVE OFFICER, Matthew Klein, is estimated to be about $1.87M . Matthew Klein owns about 102,645 units of Ptc Therapeutics, Inc common stock. In the last 3 years at Ptc Therapeutics, Inc, Matthew Klein has sold an estimated value of $1.43M worth.

What is Matthew Klein's Past Insider Trading?

Matthew Klein's largest purchase order was 5,500 units , worth over $214.39K on January 12, 2021. Matthew Klein's largest sale order was 5,500 units , worth over $383.41K on January 12, 2021. In total, Matthew Klein has made about 11 transactions over 3 years of their time at Ptc Therapeutics, Inc. Matthew Klein usually trades in January, with the busiest year in 2021 and 2023. The most recent transaction was a sale order of 1,211 units , worth over $63.02K on April 20, 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Matthew Klein

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Matthew Klein's' Mailing Address?

  • Mailing address is C/o Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080 NJ

What are Ptc Therapeutics, Inc's Past Insider Trades?

Ptc Therapeutics, Inc's most recent insider trade came on September 8, 2023 by Alethia Young who sold 11,666 units worth $464.97K . In the last 10 years, insiders at Ptc Therapeutics, Inc have sold an estimated value of $171.3M and bought an estimated value of $106.06M worth of shares. Insider trading is most common in January, with the busiest year in 2023. The most active traders at the company are Walter Stuart Peltz, CHIEF EXECUTIVE OFFICER,  Gregory Neil Almstead, CHIEF TECHNICAL OPS OFFICER,  and Elliott Mark Boulding, EXEC. VP AND CLO .

PTC THERAPEUTICS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...